Propafenone
Propafenone Hydrochloride
Antiarrhythmic
NADAC/unit
$0.1094
No Shortage
Tier 1: 117.0%
10 Manufacturers
35 ANDAs
Propafenone stabilizes heart rhythm in patients with irregular heartbeat.
vs. brand Propafenone Hydrochloride: Generic saves up to 99% per unit
Active Shortages
2025-05-14 A business decision was made to discontinue the product., Upsher-Smith Laboratories, LLC
2025-05-14 A business decision was made to discontinue the product., Upsher-Smith Laboratories, LLC
2025-05-14 A business decision was made to discontinue the product., Upsher-Smith Laboratories, LLC
Market Intelligence
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
2025-04-16 Class II Recall: Glenmark Pharmaceuticals Inc., USA
Generic Manufacturers
ANI PHARMACEUTICALS INCAUROBINDO PHARMA LTDGLENMARK PHARMACEUTICALS LTDRISING PHARMA HOLDINGS INCSINOTHERAPEUTICS INCSTRIDES PHARMA INTERNATIONAL AGUPSHER SMITH LABORATORIES LLCWATSON LABORATORIESWATSON LABORATORIES INCZYDUS LIFESCIENCES GLOBAL FZE
Explore in the Ecosystem
Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.